In marked contrast, surgical removal of first tumours plus two rounds of anti-CTLA4 treatment (pre and post), or even anti-CTLA4 (pre and post) in combined with s.c. injected PLGA-ICG-R837, exerted no appreciable inhibitory effect to the rechallenged tumours. The gene discussed is CTLA4; the disease is neoplasm.